Clinical Trials
CureVac’s COVID-19 Vaccine Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical data...
News
Algeria has become the first country in Africa to register Sputnik V vaccine
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by the National Agency...
News
AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development
AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager...
News
Kuehne+Nagel finalises agreement with Moderna for Covid-19 vaccine distribution
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, announced that they have agreed an international...
Clinical Trials
Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine
Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance from...
News
COVID-19 vaccine : Bharat Biotech to provide 55 lakh Covaxin doses at Rs 295 per dose
Bharat Biotech inked a purchase agreement with the Government of India on January 11 to provide 55 lakh doses of COVID-19 vaccine Covaxin at Rs...
News
Covid Vaccine: India Orders Over 6 Crore Doses From SII, Bharat Biotech
The government has placed orders in advanced commitments for over 6 crore doses of Covid-19 vaccine from Serum Institute of India (SII) and Bharat Biotech...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.